Cogan's syndrome with left main coronary artery occlusion

Cardiology Journal

Volumn 16, Issue 6, 2009, Pages 573-576

  Weyn, Tim ^a   Haine, Steven ^b   Conraads, Viviane ^b  

^a ZNA Middelheim   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cogan's syndrome; Heart failure; Large vessel vasculitis; Left main coronary artery occlusion

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM; GLUCOCORTICOID; METHOTREXATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PREDNISOLONE; TROPONIN I;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; AUDIOMETRY; CASE REPORT; COCHLEA PROSTHESIS; COGAN SYNDROME; CONTRAST ENHANCEMENT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; DOPPLER ECHOCARDIOGRAPHY; DRUG MEGADOSE; DRUG PULSE THERAPY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEARING LOSS; HEART CATHETERIZATION; HEART FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INNER EAR DISEASE; INTERNAL CAROTID ARTERY; LEFT CORONARY ARTERY; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION DEAFNESS; SYSTOLIC HEART MURMUR; THORAX PAIN; TINNITUS; TRANSITIONAL BLINDNESS; VASCULITIS; VERTEBRAL ARTERY; VERTIGO;

ADULT; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOVASCULAR AGENTS; COGAN SYNDROME; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY OCCLUSION; CYCLOPHOSPHAMIDE; ELECTROCARDIOGRAPHY; FEMALE; GLUCOCORTICOIDS; HEART FAILURE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MITRAL VALVE INSUFFICIENCY; PULSE THERAPY, DRUG; TREATMENT OUTCOME;

EID: 74249120630     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Cogan D. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol, 1945; 33: 144-149.
2. Chynn EW, Jakobiec FA. Cogan's syndrome: Ophthalmic, audiovestibular, and systemic manifestations and therapy. Int Ophthalmol Clin, 1996; 36: 61-72.
3. Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: Studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine, 1980; 59: 426-441.
4. McDonald TJ, Vollertsen RS, Younge BR. Cogan's syndrome: Audiovestibular involvement and prognosis in 18 patients. Laryngoscope, 1985; 95: 650-654.
5. Casselman JW, Majoor MH, Albers FW. MR of the inner ear in patients with Cogan syndrome. Am J Neuroradiol, 1994; 15: 131-138.
6. Gluth MB, Baratz KH, Matteson EL, Driscoll CL. Cogan syndrome: A retrospective review of 60 patients throughout a half century. Mayo Clin Proc, 2006; 81: 483-488.
7. Raza K, Karokis D, Kitas GD. Cogan's syndrome with Takayasu's arteritis. Br J Rheumatol. 1998; 37: 369-372.
8. Allen NB, Cox CC, Cobo M et al. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome. Am J Med, 1990; 88: 296-301.
9. Riente L, Taglione E, Berrettini S. Efficacy of methotrexate in Cogan's syndrome. J Rheumatol, 1996; 23: 1830-1831.
10. Touma Z, Nawwar R, Hadi U, Hourani M, Arayssi T. The use of TNF-alpha blockers in Cogan's syndrome. Rheumatol Int, 2007; 27: 995-996.
11. Pasanisi E, Vincenti V, Bacciu A et al. Cochlear implantation and Cogan syndrome. Otol Neurotol, 2003; 24: 601-604.